A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)

被引：0
作者：
Masashi Kanai
Etsuro Hatano
Shogo Kobayashi
Yutaka Fujiwara
Shigeru Marubashi
Atsushi Miyamoto
Hisanori Shiomi
Shoji Kubo
Shinichi Ikuta
Hiroaki Yanagimoto
Hiroaki Terajima
Hisashi Ikoma
Daisuke Sakai
Yuzo Kodama
Satoru Seo
Satoshi Morita
Tetsuo Ajiki
Hiroaki Nagano
Tatsuya Ioka
机构：
[1] Kyoto University,Department of Clinical Oncology and Pharmacogenomics, Graduate School of Medicine
[2] Kyoto University,Department of Surgery, Graduate School of Medicine
[3] Osaka University,Department of Surgery, Graduate School of Medicine
[4] National Cancer Center Hospital,Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center
[5] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Surgery
[6] National Hospital Organization Osaka National Hospital,Department of Surgery
[7] Shiga University of Medical Science,Department of Surgery
[8] Osaka City University Graduate School of Medicine,Department of Hepato
[9] Meiwa General Hospital,Biliary
[10] Kansai Medical University,Pancreatic Surgery
[11] Kitano Hospital,Department of Surgery
[12] Kyoto Prefectural University of Medicine,Department of Surgery
[13] Osaka University,Department of Gastroenterological Surgery and Oncology
[14] Kyoto University Hospital,Division of Digestive Surgery, Department of Surgery
[15] Kyoto University Graduate School of Medicine,Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine
[16] Kobe University Hospital,Department of Gastroenterology and Hepatology, Graduate School of Medicine
[17] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Biomedical Statistics and Bioinformatics
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Biliary; Gemcitabine; Cisplatin; S-1; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 300
页数：7
相关论文
共 278 条
  • [1] Leonard GD(2005)Biliary tract cancers: current concepts and controversies Expert Opin Pharmacother 6 211-223
  • [2] O’Reilly EM(1996)Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Ann Oncol 7 593-600
  • [3] Glimelius B(2007)Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials Br J Cancer 96 896-902
  • [4] Hoffman K(2010)Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 1273-1281
  • [5] Sjoden PO(2010)Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan Br J Cancer 103 469-474
  • [6] Jacobsson G(2004)S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial Clin Cancer Res 10 7860-7864
  • [7] Sellstrom H(2004)Phase II study of S-1 in patients with advanced biliary tract cancer Br J Cancer 91 1769-1774
  • [8] Enander LK(2008)S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study Cancer Chemother Pharmacol 62 849-855
  • [9] Linne T(2008)S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215-221
  • [10] Svensson C(2010)Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer Cancer Chemother Pharmacol 65 1101-1107
12345678910